5(S),6(S)-Lipoxin A4 (CAS 1256643-63-6)

5(S),6(S)-Lipoxin A4, cataloged under CAS number 1256643-63-6, is an intriguing chemical entity belonging to the lipoxin family, which are lipoxygenase-derived eicosanoids known for their complex roles in modulating inflammatory processes through non-classic pathways. This specific isomer of Lipoxin A4 is synthesized through the interaction of arachidonic acid metabolites, primarily via the concerted actions of 5-lipoxygenase and 15-lipoxygenase in leukocytes. The biologically active 5(S),6(S) configuration of Lipoxin A4 is particularly notable for its involvement in the resolution phase of inflammation, acting through specific binding to G-protein-coupled receptors on the surfaces of targeted cells. In research contexts, this compound has been utilized extensively to study its modulatory effects on the secretion and activity of cytokines and chemokines, thereby influencing the recruitment and activity of immune cells. The mechanisms by which 5(S),6(S)-Lipoxin A4 operates include the alteration of intracellular signaling cascades that regulate gene expression and cellular responses to inflammatory stimuli. Studies utilizing this lipoxin have provided deeper insights into how endogenous resolution mechanisms are crucial for restoring tissue homeostasis and preventing chronic inflammation. Through such research, significant understanding has been gained about the sophisticated network of bioactive molecules in inflammation resolution.